AnxA1 and AnxA2 are key endogenous regulators of inflammation signaling, exhibiting dysregulated expression that contributes to the chronic intestinal inflammation observed in IBD pathogenesis (84). Here, ANXA1 is linked to irritable bowel syndrome.